Business Standard

Bafna Pharmaceuticals Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Announcement Regarding Inauguration Of New Quality Control Laboratory Of Company We are delighted to announce the inauguration of new State-of-the-Art Quality Co...Read More26/04/2024
Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations 2015 For The Period Ended 31St March 2024 We are herewith submitting the Compliance Certificate under Regulation 7(3) of S...Read More24/04/2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer We hereby inform that Mr. Vishnu Vasudeva Kuppa has resigned from the position o...Read More23/04/2024
Compliance Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended 31St March 2024 We are herewith enclosing the Compliance Certificate issued under Regulation 40(...Read More22/04/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 We are herewith enclosing Certificate under Regulation 74(5) of SEBI (DP) Regula...Read More15/04/2024
Closure of Trading Window The Trading Window for the designated persons connected persons shall remain clo...Read More25/03/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication we have furnished herewith newspaper clippings of Un-audited Standalone Financia...Read More14/02/2024
Un-Audited Standalone Financial Results For The Quarter Ended December 31 2023. we wish to inform that at the meeting of the Board of Directors of the Company h...Read More12/02/2024
Board Meeting Intimation for Intimation Of Meeting Of Board Of Directors - Approval Of Q3 FY24 Financial Results. BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Dire...Read More02/02/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Pursuant to Regulation 74(5) of SEBI(DP) Regulations 2018 we enclosed herewith a...Read More11/01/2024
Board Meeting Outcome for Approval Of Financials For The Quarter Ended June 30 2023 We wish to inform that at the meeting of the Board of Directors of the Company h...Read More11/08/2023
Board Meeting Intimation for Approval Of Q1 FY24 Financial Results. BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Dire...Read More03/08/2023
Non-Applicability Of Declaration Of In Terms Of Regulation 32 Of SEBI (LODR) Regulations 2015. the Statement of Deviation and Variation of proceeds of Public Issue Right Issue...Read More13/07/2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 We enclosed herewith a certificate dated July 07 2023 received from Cameo Corpor...Read More13/07/2023
Closure of Trading Window The Trading Window for the designated persons connected persons and their immedi...Read More28/06/2023
Board Meeting Outcome for Outcome Of The Board Meeting Held On June 26 2023. Based on the recommendations of the Nomination and Remuneration Committee of Boa...Read More27/06/2023
Board Meeting Intimation for A Meeting Of The Board Of Directors Of Bafna Pharmaceuticals Limited Is Scheduled To Be Held On June 26 2023. BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Dire...Read More23/06/2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper clippings of Audited Standalone Financial Results of the Company for t...Read More29/05/2023
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A <b>Format of Initial Disclosure to be made by an entity identified as a Large Co...Read More05/05/2023
Compliance Certificate Under Reg 7(3) Of LODR For The Year Ended 31.03.2023 Compliance certificate under Reg 7(3) of LODR for the year ended 31.03.202315/04/2023

Load more